Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Rosseti South reported for 3 months of 2023 by RAS
4/28/23
MRKY
Rosseti Volga reported for 3 months of 2023 by RAS
4/28/23
MRKV
Samolet reported for 2022 by IFRS
4/28/23
SMLT
Gilead Sciences announced a quarterly dividend
4/28/23
GILD
Shareholders of Moscow Exchange could not make a decision on dividends
4/28/23
MOEX
Mother and Child summed up the results of work in the 1st quarter
4/28/23
MDMG
VKontakte's first NFT collection sold out in 30 minutes
4/28/23
VKCO
First Solar reported for 3 months of 2023
4/28/23
FSLR
Abbott bought Cardiovascular Systems
4/28/23
CSII
Abbott bought Cardiovascular Systems
4/28/23
ABT
«
Previous
632
633
634
635
636
637
638
639
640
641
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)